Ubs Group Ag Adamis Pharmaceuticals Corp Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.1 - $0.3 $8,724 - $26,173
87,244 Added 213.01%
128,202 $15,000
Q4 2022

Feb 08, 2023
BUY
$0.14 - $0.22 $5,734 - $9,010
40,958 New
40,958 $6,000
Q2 2022

Aug 10, 2022
BUY
$0.34 - $0.57 $6,572 - $11,018
19,331 Added 29.0%
85,984 $43,000
Q1 2022

May 16, 2022
SELL
$0.55 - $0.73 $43,280 - $57,444
-78,691 Reduced 54.14%
66,653 $39,000
Q4 2021

Feb 14, 2022
BUY
$0.57 - $1.23 $54,346 - $117,273
95,344 Added 190.69%
145,344 $89,000
Q3 2021

Nov 15, 2021
SELL
$0.92 - $1.18 $8,932 - $11,456
-9,709 Reduced 16.26%
50,000 $49,000
Q2 2021

Aug 13, 2021
BUY
$0.66 - $1.23 $6,407 - $11,942
9,709 Added 19.42%
59,709 $66,000
Q1 2021

May 12, 2021
SELL
$0.54 - $1.79 $10,164 - $33,693
-18,823 Reduced 27.35%
50,000 $47,000
Q4 2020

Feb 11, 2021
BUY
$0.4 - $1.01 $23,557 - $59,481
58,893 Added 593.08%
68,823 $33,000
Q3 2020

Nov 12, 2020
SELL
$0.52 - $1.45 $26,855 - $74,885
-51,645 Reduced 83.87%
9,930 $8,000
Q2 2020

Jul 31, 2020
BUY
$0.33 - $0.66 $16,459 - $32,918
49,876 Added 426.33%
61,575 $33,000
Q1 2020

May 01, 2020
SELL
$0.33 - $0.89 $3,781 - $10,199
-11,460 Reduced 49.48%
11,699 $4,000
Q4 2019

Feb 14, 2020
BUY
$0.51 - $1.26 $8,638 - $21,343
16,939 Added 272.33%
23,159 $17,000
Q3 2019

Nov 14, 2019
BUY
$0.7 - $1.46 $808 - $1,686
1,155 Added 22.8%
6,220 $5,000
Q4 2018

Feb 14, 2019
SELL
$2.1 - $3.21 $7,287 - $11,138
-3,470 Reduced 40.66%
5,065 $11,000
Q3 2018

Nov 14, 2018
SELL
$2.25 - $4.8 $8,424 - $17,971
-3,744 Reduced 30.49%
8,535 $30,000
Q2 2018

Aug 14, 2018
BUY
$3.2 - $4.7 $18,080 - $26,555
5,650 Added 85.23%
12,279 $39,000
Q1 2018

May 15, 2018
BUY
$2.55 - $4.85 $15,705 - $29,871
6,159 Added 1310.43%
6,629 $23,000
Q4 2017

Feb 14, 2018
SELL
$3.5 - $5.65 $5,733 - $9,254
-1,638 Reduced 77.7%
470 $2,000
Q3 2017

Nov 14, 2017
BUY
$4.5 - $5.65 $7,371 - $9,254
1,638 Added 348.51%
2,108 $11,000
Q1 2017

Nov 14, 2017
BUY
N/A
470
470 $2,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email